Health
MS patients receiving aCD20 treatment mount robust T-cell responses to COVID-19 vaccines – News-Medical.Net
New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells…
New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells that contribute to the MS attacks – are able to mount robust T-cell responses to the mRNA COVID-19 vaccines, despite having a muted…
Continue Reading
-
General23 hours agoTrump’s tariffs: a bad idea executed badly
-
Business10 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
General15 hours agoVolodymyr Zelenskyy claims Chinese soldiers fighting alongside Russians in Ukraine
-
General22 hours agoHow what happens on financial markets affects the broader economy